20969 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Cytokines; Lymphokines; Interferons; Interleukins [IL] IL-6
USE OF IL-6/IL-6 CHIMERA IN HUNTINGTON'S DISEASE
#302Method of modulating fertility in animals
#303Hepatitis C virus inhibitors
#304Novel delivery of immune response modifiers for removal of chronic tattoos
#305Enhanced ocular neuroprotection and neurostimulation
#306STAT3 agonists and antagonists and therapeutic uses thereof
#307Vaccine immunotherapy for immune suppressed patients
#308Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
#309Methods of using retro-inverso peptides derived from interleukin-6
#310Vaccine immunotherapy for immune suppressed patients
#311Vaccine immunotherapy
#312Enhanced ocular neuroprotection and neurostimulation
#313Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
#314Enhanced recovery following ocular surgery
#315Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
#316Repair and regeneration of ocular tissue using postpartum-derived cells
#317Methods for modulating topical inflammatory response
#318Immunotherapy for immune suppressed patients
#319Postpartum-derived cells for use in treatment of disease of the heart and circulatory system
#320Methods for repressing B cell autoantibody secretion and for treating autoimmune disorders by administration of hematopoietic stem cells and macrophage-colony stimulating factor
#321Hepatitis C virus inhibitors
#322Pharmaceutical formulations for sustained drug delivery
#323Inhibitors of HCV replication
#324Cartilage and bone repair and regeneration using postpartum-derived cells
#325Method of differentiating umbilical cord tissue into a chondrogenic phenotype
#326Cartilage and bone repair and regeneration using postpartum-derived cells
#327Cartilage and bone repair and regeneration using postpartum-derived cells
#328Soft tissue repair and regeneration using postpartum-derived cells and cell products
#329Means and methods for the modulation of arteriogenesis
#330Ex-vivo rescue of hematopoietic stem cells after lethal irradiation
#331Methods of suppressing microglial activation
#332Compositions and methods for treating cancer with an oncolytic viral agent
#333Use of il6r/il6 chimera in nerve cell regeneration
#334Complex immuno-gene medical composition for inhibiting tumor cells
#335Use of cardiotrophin-1 to promote wound healing and counteract overt fibrosis
#336HIV-encoded chemoattractant
#337Proteins with IL-6 inhibiting activity
#338Vaccine immunotherapy for immune suppressed patients
#339Iminothiazolidinones as inhibitors of HCV replication
#340Use of interleukin-6 antagonists for the treatment of diseases characterized by high levels of aromatase
#341Combination pharmaceutical agents as inhibitors of HCV replication
#342Postpartum cells derived from placental tissue, and methods of making and using the same
#343Postpartum-derived cells for use in treatment of disease of the heart and circulatory system
#344Soft tissue repair and regeneration using postpartum-derived cells
#345Use of gp130 activators in diabetic neuropathy
#346Postpartum cells isolated from umbilical cord tissue, and methods of making and using the same
#347Treatment of retinitis pigmentosa with human umbilical cord cells
#348Regeneration and repair of neural tissue using postpartum-derived cells
#349Cartilage and bone repair and regeneration using postpartum-derived cells
#350Methods and compositions using AMPK activators for pharmacological prevention of chronic pain